Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
201 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
Rank Status Study
1 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
2 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
3 Not yet recruiting Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
4 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
5 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED
6 Unknown  Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Condition: Cerebral Malaria
Interventions: Drug: inhaled nitric oxide;   Drug: Placebo
7 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
8 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
9 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
10 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
11 Recruiting Galectin-3 as a Biomarker in Patients With Chagas Disease
Condition: Chagas Disease.
Intervention:
12 Recruiting Miltefosine for Children With PKDL
Condition: Post Kala Azar Dermal Leishmaniasis
Intervention: Drug: Miltefosine
13 Unknown  Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine
Conditions: Visceral Leishmaniasis;   Immune Response;   Treatment
Interventions: Drug: N-acetylcysteine;   Drug: Pentavalent antimonial
14 Recruiting Tracking Resistance to Artemisinin (TRAC)
Condition: Falciparum Malaria
Interventions: Drug: Artesunate 2;   Drug: Artesunate 4
15 Not yet recruiting DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax
Conditions: Plasmodium Falciparum Malaria;   Plasmodium Vivax Malaria
Interventions: Drug: DSM265 400mg;   Drug: DSM265 xmg;   Drug: DSM265 ymg
16 Recruiting P. Vivax CQ Resistance in Cambodia
Condition: Vivax Malaria
Intervention: Drug: Chloroquine diphosphate
17 Unknown  A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
Conditions: Uncomplicated Falciparum Malaria;   Vivax Malaria
Interventions: Drug: Dihydroartemisinin + Piperaquine (Artekin);   Drug: artesunate-sulphadoxin/pyrimethamine, chloroquine
18 Recruiting Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults
Condition: Malaria
Interventions: Biological: FMP012 with AS01B adjuvant system;   Other: P falciparum Controlled Human Malaria Infection (CHMI)
19 Not yet recruiting CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
Condition: Chagas Disease
Interventions: Drug: Nifurtimox;   Drug: Benznidazole
20 Recruiting Providers' Compliance to Malaria Treatment
Condition: Malaria
Intervention: Other: SMS reminders

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years